Skip to main content
Clinical Trials/CTRI/2014/02/004429
CTRI/2014/02/004429
Other
N/A

Feasibility and efficacy study of a novel device designed to manage fecal incontinence in hospitalized bed-ridden patients.

Consure Medical Pvt Ltd0 sites10 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Fecal Incontinence in bed-ridden patients
Sponsor
Consure Medical Pvt Ltd
Enrollment
10
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Consure Medical Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Patients in neurology and critical care ward that require nursing care for the management of fecal incontinence due to a central neurogenic condition. The volunteers should meet all of the following criteria:
  • Patients must be between 18 â?? 75 years of age (Both sexes).
  • Fecal incontinence must be caused due to an intracranial or spinal disorder.
  • Patient is confirmed to have more than 2 stool/bowel episodes in the last 24 hours.
  • Patient has achieved hemodynamic stability.
  • Patient or a legal representative of the patient gives written consent for the study.

Exclusion Criteria

  • Following patients will be not be included in this feasibility study:
  • Fecal incontinence caused due to local causes, i.e. any trauma, disease or condition of the muscular apparatus of the ano\-rectal region.
  • Patients with significant hemorrhoids, growth, ulcers, malignancy, fissure, stricture and local pathology as observed during protoscopic examination. Short\-listed patients with external or internal hemorrhoids that are classified as Grade III or lower can be enrolled in the study.
  • Patients on oral anti\-coagulation.
  • Patients that have planned MRI examination over the duration of the study.
  • Patients with recent history of colo\-rectal surgeries or therapeutic procedures.
  • Patients with or having suspicion of ulcerative colitis, Crohnâ??s disease or rectal ulcers.
  • Patients suspected to have intestinal tuberculosis.
  • Patients on inotropic drugs.
  • Patients with confirmed pregnancy or suspected to be pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials